• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Down regulation/antagonist of Acetylcholine (primarily muscarinic)

down regulation antagonist muscarinic receptors

  • Please log in to reply
3 replies to this topic

#1 Tom_

  • Guest
  • 1,120 posts
  • -31
  • Location:england

Posted 05 June 2013 - 01:11 AM


Some antipsychotics and TCA's are both antimuscarinic. Are there any less dangerous drugs that have similar effects?

Muscarinic neurons are heavily associated with depression.

Thanks guys,

#2 datrat

  • Guest
  • 144 posts
  • 3
  • Location:san diego

Posted 05 June 2013 - 05:37 AM

You might consider trying a scopolamine transdermal patch used to prevent seasickness. It wouldn't be as effective as intravenous, but it might work.

Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.

The muscarinic cholinergic receptor system has been implicated in the pathophysiology of depression, with physiological evidence indicating this system is overactive or hyperresponsive in depression and with genetic evidence showing that variation in genes coding for receptors within this system are associated with higher risk for depression. In studies aimed at assessing whether a reduction in muscarinic cholinergic receptor function would improve depressive symptoms, the muscarinic receptor antagonist scopolamine manifested antidepressant effects that were robust and rapid relative to conventional pharmacotherapies. Here, we review the data from a series of randomized, double-blind, placebo-controlled studies involving subjects with unipolar or bipolar depression treated with parenteral doses of scopolamine. The onset and duration of the antidepressant response are considered in light of scopolamine's pharmacokinetic properties and an emerging literature that characterizes scopolamine's effects on neurobiological systems beyond the cholinergic system that appear relevant to the neurobiology of mood disorders. Scopolamine infused at 4.0 μg/kg intravenously produced robust antidepressant effects versus placebo, which were evident within 3 days after the initial infusion. Placebo-adjusted remission rates were 56% and 45% for the initial and subsequent replication studies, respectively. While effective in male and female subjects, the change in depression ratings was greater in female subjects. Clinical improvement persisted more than 2 weeks following the final infusion. The timing and persistence of the antidepressant response to scopolamine suggest a mechanism beyond that of direct muscarinic cholinergic antagonism. These temporal relationships suggest that scopolamine-induced changes in gene expression and synaptic plasticity may confer the therapeutic mechanism.
Published by Elsevier Inc. PMID: 23200525 [PubMed - in process]

sponsored ad

  • Advert
Click HERE to rent this advertising spot for BRAIN HEALTH to support LongeCity (this will replace the google ad above).

#3 brainslugged

  • Guest
  • 305 posts
  • 39
  • Location:Georgia, US
  • NO

Posted 05 June 2013 - 02:40 PM

Many SSRIs also have antimuscarinic properties.

So do older antihistamines like diphenhydramine.

Benzatropine looks interesting. It is used for parkinson's and it an anticholinergic as well as a DRI.

Datrat's suggestion of scopolamine looks to the best as far as I can tell, though.

sponsored ad

  • Advert
Click HERE to rent this advertising spot for BRAIN HEALTH to support LongeCity (this will replace the google ad above).

#4 lammas2

  • Guest
  • 137 posts
  • 33
  • Location:Finland

Posted 05 June 2013 - 03:01 PM

http://www.longecity...-acetylcholine/

If I could get hold of pure myristicin, I'd definitely try it.





Also tagged with one or more of these keywords: down regulation, antagonist, muscarinic receptors

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users